Cargando…

15-deoxy-Δ(12,14)-Prostaglandin J(2) inhibits human soluble epoxide hydrolase by a dual orthosteric and allosteric mechanism

Human soluble epoxide hydrolase (hsEH) is an enzyme responsible for the inactivation of bioactive epoxy fatty acids, and its inhibition is emerging as a promising therapeutical strategy to target hypertension, cardiovascular disease, pain and insulin sensitivity. Here, we uncover the molecular bases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abis, Giancarlo, Charles, Rebecca L., Kopec, Jolanta, Yue, Wyatt W., Atkinson, R. Andrew, Bui, Tam T. T., Lynham, Steven, Popova, Simona, Sun, Yin-Biao, Fraternali, Franca, Eaton, Philip, Conte, Maria R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525171/ https://www.ncbi.nlm.nih.gov/pubmed/31123712 http://dx.doi.org/10.1038/s42003-019-0426-2

Ejemplares similares

15-deoxy-Δ(12,14)-prostaglandin J(2) in neurodegenerative diseases and cancers
por: Yagami, Tatsurou, et al.
Publicado: (2017)

Rac1 modification by an electrophilic 15-deoxy Δ(12,14)-prostaglandin J(2) analog
por: Wall, S.B., et al.
Publicado: (2015)

Expression, purification, and characterisation of human soluble Epoxide Hydrolase (hsEH) and of its functional C-terminal domain
por: Abis, Giancarlo, et al.
Publicado: (2019)

Isothermal Titration Calorimetry Enables Rapid Characterization of Enzyme Kinetics and Inhibition for the Human Soluble Epoxide Hydrolase
por: Abis, Giancarlo, et al.
Publicado: (2019)

Feedback Control of the Arachidonate Cascade in Osteoblastic Cells by 15-deoxy-Δ(12,14)-Prostaglandin J(2)
por: Ishino, Hidetaka, et al.
Publicado: (2008)

15-Deoxy-△(12,14)-Prostaglandin J(2) Promotes Resolution of Experimentally Induced Colitis
por: Kim, Wonki, et al.
Publicado: (2021)

15-Deoxy-Δ(12,14)-prostaglandin J(2) Induces Apoptosis and Upregulates SOCS3 in Human Thyroid Cancer Cells
por: Trindade-da-Silva, Carlos Antônio, et al.
Publicado: (2016)

Proteomic Identification of Protein Targets for 15-Deoxy-Δ(12,14)-Prostaglandin J(2) in Neuronal Plasma Membrane
por: Yamamoto, Yasuhiro, et al.
Publicado: (2011)

15-Deoxy-Δ(12,14)-Prostaglandin J(2) Inhibits Macrophage Colonization by Salmonella enterica Serovar Typhimurium
por: Buckner, Michelle M. C., et al.
Publicado: (2013)

15-deoxy-delta(12,14)-prostaglandin J(2 )induces apoptosis in human articular chondrocytes
por: Masuko-Hongo, K, et al.
Publicado: (2003)

15-Deoxy-Δ(12,14) Prostaglandin J(2) Reduces the Formation of Atherosclerotic Lesions in Apolipoprotein E Knockout Mice
por: Seno, Takahiro, et al.
Publicado: (2011)

Correction: Proteomic Identification of Protein Targets for 15-Deoxy-Δ(12,14)-Prostaglandin J(2) in Neuronal Plasma Membrane
por: Yamamoto, Yasuhiro, et al.
Publicado: (2011)

A thiol redox sensor in soluble epoxide hydrolase enables oxidative activation by intra-protein disulfide bond formation
por: Charles, Rebecca L., et al.
Publicado: (2021)

15-Deoxy-Δ(12,14)-Prostaglandin J(2) Modifies Components of the Proteasome and Inhibits Inflammatory Responses in Human Endothelial Cells
por: Marcone, Simone, et al.
Publicado: (2016)

The Effects of Co-Treatment of 9-cis-Retinoic Acid and 15-Deoxy-Δ (12,14)-prostaglandin J2 on Microglial Activation
por: Hsu, Pei-Chien, et al.
Publicado: (2011)

Cytotoxic effects of 15-deoxy-Δ12,14-prostaglandin J2 alone and in combination with dasatinib against uterine sarcoma in vitro
por: Kawakita, Takako, et al.
Publicado: (2017)

Synergistic effects of 15-deoxy Δ(12,14)-prostaglandin J(2) on the anti-tumor activity of doxorubicin in renal cell carcinoma
por: Yamamoto, Yasuhiro, et al.
Publicado: (2016)

Changes in the Th1 : Th2 Cytokine Bias in Pregnancy and the Effects of the Anti-Inflammatory Cyclopentenone Prostaglandin 15-Deoxy-Δ(12,14)-Prostaglandin J(2)
por: Sykes, Lynne, et al.
Publicado: (2012)

Effects of 15-Deoxy-Δ(12,14)-Prostaglandin J2 (15d-PGJ2) and Rosiglitazone on Human Vδ2(+) T Cells
por: Li, Haishan, et al.
Publicado: (2009)

15-deoxy-delta12,14-prostaglandin J2 attenuates endothelial-monocyte interaction: implication for inflammatory diseases
por: Prasad, Ratna, et al.
Publicado: (2008)

15-Deoxy-Δ(12,14)-prostaglandin J(2) Exerts Antioxidant Effects While Exacerbating Inflammation in Mice Subjected to Ureteral Obstruction
por: Nilsson, Line, et al.
Publicado: (2017)

A plausible involvement of plasmalemmal voltage‐dependent anion channel 1 in the neurotoxicity of 15‐deoxy‐Δ(12,14)‐prostaglandin J(2)
por: Koma, Hiromi, et al.
Publicado: (2020)

Bitopic ligands: all-in-one orthosteric and allosteric
por: Kamal, Maud, et al.
Publicado: (2009)

15-Deoxy-Delta-12,14-Prostaglandin J(2) Inhibits Lung Inflammation and Remodeling in Distinct Murine Models of Asthma
por: Coutinho, Diego S., et al.
Publicado: (2017)

Transcription of Liver X Receptor Is Down-Regulated by 15-Deoxy-Δ(12,14)-Prostaglandin J(2) through Oxidative Stress in Human Neutrophils
por: Alba, Gonzalo, et al.
Publicado: (2012)

15-Deoxy-Δ(12,14)-Prostaglandin J(2) Inhibits Osteolytic Breast Cancer Bone Metastasis and Estrogen Deficiency-Induced Bone Loss
por: Kim, Ki Rim, et al.
Publicado: (2015)

15-Deoxy-Δ(12,14)-prostaglandin J2 promotes phosphorylation of eukaryotic initiation factor 2α and activates the integrated stress response
por: Tauber, Devin, et al.
Publicado: (2019)

15-Deoxy-Δ(12,14)-prostaglandin J(2) Induces Epithelial-to-mesenchymal Transition in Human Breast Cancer Cells and Promotes Fibroblast Activation
por: Choi, Jeehye, et al.
Publicado: (2020)

15-Deoxy-∆-(12,14)-Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-γ: Function and Mechanism
por: Li, Jingjing, et al.
Publicado: (2019)

Effect of 15-Deoxy-∆(12,14)-prostaglandin J(2) Nanocapsules on Inflammation and Bone Regeneration in a Rat Bone Defect Model
por: Tang, Qi, et al.
Publicado: (2017)

Interleukin-6 Synthesis in Human Chondrocytes Is Regulated via the Antagonistic Actions of Prostaglandin (PG)E(2) and 15-deoxy-Δ(12,14)-PGJ(2)
por: Wang, Pu, et al.
Publicado: (2011)

Sensitive mass spectrometric assay for determination of 15-deoxy-Δ(12,14)-prostaglandin J(2) and its application in human plasma samples of patients with diabetes
por: Morgenstern, Jakob, et al.
Publicado: (2017)

15-Deoxy-Δ(12,14)-prostaglandin J(2) inhibits migration of human thyroid carcinoma cells by disrupting focal adhesion complex and adherens junction
por: Wu, Ya-Chieh, et al.
Publicado: (2017)

STAT3 as a Potential Target for Tumor Suppressive Effects of 15-Deoxy-Δ(12,14)-prostaglandin J(2) in Triple Negative Breast Cancer
por: Kim, Su-Jung, et al.
Publicado: (2021)

Cytotoxicity of 15-Deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent Pathway and the Involvement of the JNK and Akt Pathway in Renal Cell Carcinoma
por: Fujita, Megumi, et al.
Publicado: (2012)

15-Deoxy-Δ(12,14)-prostaglandin J(2) as a potential regulator of bone metabolism via PPARγ-dependent and independent pathways: a review
por: Xiong, Zhencheng, et al.
Publicado: (2019)

15-Deoxy-Δ(12,14)-prostaglandin J(2) Upregulates VEGF Expression via NRF2 and Heme Oxygenase-1 in Human Breast Cancer Cells
por: Kim, Eun-Hee, et al.
Publicado: (2021)

Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation
por: Mohamed, Tasnim S., et al.
Publicado: (2015)

Structure of CC Chemokine Receptor 2 with Orthosteric and Allosteric Antagonists
por: Zheng, Yi, et al.
Publicado: (2016)

Analysis of equilibrium binding of an orthosteric tracer and two allosteric modulators
por: Jakubík, Jan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j8vvg9vp2jo72o1mflri5mtka5